Form D · Other Health Care
Lorelei Integrated Therapeutics, Inc.
Houston, TX · CIK 0001937199
Offering snapshot reported Jul 8, 2022 · SEC filing
- Reported sold
- $1.04M Offering amount: $2M
- Investors reported
- 7 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 14, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 8, 2022 | Initial | $1,035,000 | No comparison | 7 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-451575
Source: Form D, filed Jul 8, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joel Herger | Director, Executive |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1923 Washington Avenue
Houston, TX, 77007
Houston, TX, 77007